Brief: Vistagen Regains Full Compliance With Nasdaq Listing Requirements
23/06/2023 13:31
June 23 (Reuters) - Vistagen Therapeutics Inc VTGN.O :
* VISTAGEN REGAINS FULL COMPLIANCE WITH NASDAQ LISTING
REQUIREMENTS
Source text for Eikon: ID:nBw7sjWJ4a
Further company coverage: VTGN.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Vistagen Therapeutics
See all newsBrief: Vistagen TherapeuticsSays Fasedienol Nasal Spray Well-Tolerated With No New Drug-Related Safety Findings After 12 Months
VistaGen Q1 revenue rises on licensing agreement expiration
Brief: VistaGen Q1 EPS USD -0.3
Vistagen Therapeutics Inc expected to post a loss of 36 cents a share - Earnings Preview
Brief: Vistagen Appoints Douglas J. Williamson To Its Board Of Directors